tirzepatide vs semaglutide weight loss mechanism VS. — WHAT'S THE ACTUAL DIFFERENCE? Both are used for medical management. Both work through GLP-1 pathways. But they're not the same medication, and understanding the difference helps you tirzepatide and semaglutide mechanism of

Abstract Introduction Tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist, provides clinically meaningful improvements in glycaemic control and body weight loss in people with type 2 diabetes

By mimicking the action of two hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), it effectively enhances insulin secretion in response to high blood sugar levels while simultaneously slowing down gastric emptying

Reporting of the study protocol follows the STROBE guidelines

Perhaps surprisingly, given the inflammatory pathways discussed above, the researchers also found a heightened risk of arthritic disorders in patients using GLP-1 drugs, compared to usual treatment